MYOVIEW Side Effects

6942094-5 | Blister, Diarrhoea, Dizziness, Dry Gangrene, Eschar, Injection Site Discolouration, Nausea, Renal Failure, Skin Discolouration
on Aug 10, 2010 Female patient from CANADA , 76 years of age, weighting 180.0 lb, was diagnosed with chest pain (What is chest pain?), surgery (What is surgery?) and was treated with Myoview (View Usage). Patient experienced the following unwanted or unexpected effects: blister, diarrhoea, dizziness (What is dizziness?), dry gangrene, eschar, injection site discolouration, nausea (What is nausea?), renal failure, skin discolouration. Myoview dosage: 414.4 Mbq, Single Dose, I.v.; 1207.1 Mbq, Single Dose, I.v.. During the same period patient was treated with PERSANTINE (46.5 Mg, Single Dose, I.v.) (View Persantine Review and Persantine Label ), AMINOPHYLLINE (100 Mg, Single Dose, I.v.) (View Aminophylline Review and Aminophylline Label ), ESOMEPRAZOLE MAGNESIUM (NEXIUM) (View Esomeprazole Magnesium (nexium) Review and Esomeprazole Magnesium (nexium) Label ), SYNTHROID (View Synthroid Review and Synthroid Label ). Patient was hospitalized.

6907378-5 | Blister, Diarrhoea, Dizziness, Renal Failure, Skin Discolouration
Patient was taking Myoview (View Usage). Patient had the following side effects: blister, diarrhoea, dizziness (What is dizziness?), renal failure, skin discolouration on Jul 19, 2010 from CANADA Additional patient health information: Female patient , 76 years of age, weighting 180.0 lb, was diagnosed with chest pain (What is chest pain?) and. Myoview dosage: 414.4 Mbq, Single Dose, I.v.; 1207.1 Mbg, Single Dose, I.v.. During the same period patient was treated with PERSANTINE (46.5 Mg, Single Dose, I.v.) (View Persantine Review and Persantine Label ), AMINOPHYLLINE (100 Mg, Single Dose, I.v.) (View Aminophylline Review and Aminophylline Label ), TECHNETIUM (TC99M) (SODIUM PERTECHNETATE TC99M) (View Technetium (tc99m) (sodium Pertechnetate Tc99m) Review and Technetium (tc99m) (sodium Pertechnetate Tc99m) Label ), ESOMEPRAZOLE MAGNESIUM (NEXIUM) (View Esomeprazole Magnesium (nexium) Review and Esomeprazole Magnesium (nexium) Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), TYLENOL W/ CODEINE NO. 3 (View Tylenol W/ Codeine No. 3 Review and Tylenol W/ Codeine No. 3 Label ). Patient was hospitalized.

6871120-7 | Blister, Diarrhoea, Dizziness, Injection Site Discolouration, Nausea, Renal Failure
Adverse event was reported on Jul 13, 2010 by a Female patient taking Myoview (View Usage) (Dosage: 414.4 Mbq, Single Dose , I.v.; 1207.1 Mbq, Single Dose, I.v.) was diagnosed with chest pain (What is chest pain?), surgery (What is surgery?) and. Location: CANADA , 76 years of age, weighting 180.0 lb, After Myoview was administered, patient had the following side effects: blister, diarrhoea, dizziness (What is dizziness?), injection site discolouration, nausea (What is nausea?), renal failure. During the same period patient was treated with PERSANTINE (46.5 Mg, Single Dose, I.v.) (View Persantine Review and Persantine Label ), AMINOPHYLLINE (100 Mg, Single Dose , I.v.) (View Aminophylline Review and Aminophylline Label ), ESOMEPRAZOLE MAGNESIUM (NEXIUM) (View Esomeprazole Magnesium (nexium) Review and Esomeprazole Magnesium (nexium) Label ), SYNTHROID (View Synthroid Review and Synthroid Label ). Patient was hospitalized.

6627639-7 | Enterobacter Infection, Nosocomial Infection, Tremor
on Mar 01, 2010 Male patient from UNITED STATES , 52 years of age, was diagnosed with chest pain (What is chest pain?), dyspnoea, coronary artery disease (What is coronary artery disease?) and was treated with Myoview (View Usage). Patient experienced the following unwanted or unexpected effects: enterobacter infection, nosocomial infection, tremor. Myoview dosage: 1110 Mbq, Single Dose, I.v.; 1221 Mbq, Single Dose I.v.. Patient was hospitalized.


6579855-0 | Nausea
on Feb 09, 2010 Female patient from UNITED STATES , 62 years of age, weighting 174.0 lb, was diagnosed with cardiac stress test and was treated with Myoview (View Usage). Patient had the following side effects: nausea (What is nausea?). Myoview dosage: Once Iv.

6434964-1 | Erythema Multiforme
Patient was taking Myoview (View Usage). After Myoview was administered, patient had the following side effects: erythema multiforme on Oct 28, 2009 from SWEDEN Additional patient health information: Female patient , 61 years of age, . Myoview dosage: Single Dose, I.v..

6434960-4 | Erythema Multiforme
Adverse event was reported on Oct 28, 2009 by a Female patient taking Myoview (View Usage) (Dosage: Single Dose, I.v.; Single Dose) . Location: NORWAY , 61 years of age, Patient experienced the following unwanted or unexpected effects: erythema multiforme. During the same period patient was treated with BUDESONIDE (BUDENOFALK) (View Budesonide (budenofalk) Review and Budesonide (budenofalk) Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), METOPROLOL TARTRATE (SELOKEN) (View Metoprolol Tartrate (seloken) Review and Metoprolol Tartrate (seloken) Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

6414361-5 | Erythema Multiforme
on Oct 09, 2009 Female patient from SWEDEN , 61 years of age, was treated with Myoview (View Usage). Patient had the following side effects: erythema multiforme. Myoview dosage: Single Dose, I.v..

5958124-3 | Urticaria
on Nov 17, 2008 Male patient from UNITED STATES , 73 years of age, weighting 160.0 lb, was diagnosed with cardiac stress test and was treated with Myoview (View Usage). After Myoview was administered, patient had the following side effects: urticaria. Myoview dosage: . During the same period patient was treated with ADENOSINE (View Adenosine Review and Adenosine Label ).

5891043-X | Dialysis, Renal Failure
Patient was taking Myoview (View Usage). Patient experienced the following unwanted or unexpected effects: dialysis (What is dialysis?), renal failure on Sep 18, 2008 from UNITED STATES Additional patient health information: Female patient , 51 years of age, weighting 155.0 lb, was diagnosed with diabetes mellitus, hypertension, renal failure and. Myoview dosage: Rest-10.7 Mci 8:00am Iv Bolus Stress-30.6 Mci 12:00pm Iv Bolus. During the same period patient was treated with . (View . Review and . Label ). Patient was hospitalized.

5885654-5 | Erythema Multiforme
Adverse event was reported on Sep 05, 2008 by a Female patient taking Myoview (View Usage) (Dosage: Nr, Single Dose, I.v.) . Location: NORWAY , 61 years of age, Patient had the following side effects: erythema multiforme. During the same period patient was treated with BUDENOSIDE (BUDENOFALK) (View Budenoside (budenofalk) Review and Budenoside (budenofalk) Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), METOPROLOL TARTRATE (SELOKEN) (View Metoprolol Tartrate (seloken) Review and Metoprolol Tartrate (seloken) Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), GLUCOSAMINE (GLUKOSAMIN) (View Glucosamine (glukosamin) Review and Glucosamine (glukosamin) Label ).

5859227-4 | Erythema Multiforme
on Aug 19, 2008 Female patient from NORWAY , 61 years of age, was treated with Myoview (View Usage). After Myoview was administered, patient had the following side effects: erythema multiforme. Myoview dosage: Nr, Single Dose. During the same period patient was treated with BUDESONIDE (BUDENOFALK) (View Budesonide (budenofalk) Review and Budesonide (budenofalk) Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), METOPROLOL TARTRATE (SELOKEN) (View Metoprolol Tartrate (seloken) Review and Metoprolol Tartrate (seloken) Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

5824072-2 | Hepatitis B, Therapeutic Product Contamination
on Jul 08, 2008 Male patient from UNITED STATES , 51 years of age, was treated with Myoview (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis b (What is hepatitis b?), therapeutic product contamination. Myoview dosage: Single Dose, I.v.. During the same period patient was treated with THALLOUS CHLORIDE TL 201 (View Thallous Chloride Tl 201 Review and Thallous Chloride Tl 201 Label ).

5824057-6 | Hepatitis B, Therapeutic Product Contamination
Patient was taking Myoview (View Usage). Patient had the following side effects: hepatitis b (What is hepatitis b?), therapeutic product contamination on Jul 08, 2008 from UNITED STATES Additional patient health information: Female patient , 52 years of age, . Myoview dosage: Single Dose, I.v.. During the same period patient was treated with THALLOUS CHLORIDE TL 201 (View Thallous Chloride Tl 201 Review and Thallous Chloride Tl 201 Label ).

5792696-7 | Hepatitis B
Adverse event was reported on Jun 10, 2008 by a Male patient taking Myoview (View Usage) (Dosage: Single Dose, I. V.) . Location: UNITED STATES , 51 years of age, After Myoview was administered, patient had the following side effects: hepatitis b (What is hepatitis b?). During the same period patient was treated with THALLOUS CHLORIDE TL 201 (View Thallous Chloride Tl 201 Review and Thallous Chloride Tl 201 Label ).

5792695-5 | Hepatitis B, Transmission Of An Infectious Agent Via A Medicinal Product
on Jun 12, 2008 Female patient from UNITED STATES , 52 years of age, was treated with Myoview (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis b (What is hepatitis b?), transmission of an infectious agent via a medicinal product. Myoview dosage: Single Dose, I.v.. During the same period patient was treated with THALLOUS CHLORIDE TL 201 (View Thallous Chloride Tl 201 Review and Thallous Chloride Tl 201 Label ).

5660467-8 | Hyperglycaemia, Incontinence, Influenza Like Illness, Upper Respiratory Tract Infection
on Feb 27, 2008 Male patient from SWEDEN , 81 years of age, was treated with Myoview (View Usage). Patient had the following side effects: hyperglycaemia, incontinence, influenza like illness, upper respiratory tract infection. Myoview dosage: 0.399 Mbq, Single Dose, I.v.. During the same period patient was treated with ADENOSIN (View Adenosin Review and Adenosin Label ). Patient was hospitalized.

5474850-7 | Dermatitis Bullous, Skin Exfoliation
Patient was taking Myoview (View Usage). After Myoview was administered, patient had the following side effects: dermatitis bullous, skin exfoliation on Sep 18, 2007 from NORWAY Additional patient health information: Male patient , 57 years of age, weighting 209.4 lb, . Myoview dosage: 261 Mbq, Single Dose, I.v.. During the same period patient was treated with DIAMICRON (GLICLAZIDE) (View Diamicron (gliclazide) Review and Diamicron (gliclazide) Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ), VASTAREL (TRIMETAZIDINE) (View Vastarel (trimetazidine) Review and Vastarel (trimetazidine) Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), AVANDIA (View Avandia Review and Avandia Label ).

5463942-4 | Cold Sweat, Convulsion, Hyperhidrosis, Infusion Related Reaction, Nausea
Adverse event was reported on Sep 10, 2007 by a Male patient taking Myoview (View Usage) (Dosage: 444 Mbg, Single Dose, I.v.) . Location: UNITED STATES , 54 years of age, Patient experienced the following unwanted or unexpected effects: cold sweat, convulsion, hyperhidrosis, infusion related reaction, nausea (What is nausea?).

5422323-X | Anaphylactoid Reaction
on Nov 28, 2006 Male patient from UNITED STATES , 84 years of age, was treated with Myoview (View Usage). Patient had the following side effects: anaphylactoid reaction. Myoview dosage: 259 Meq, Single Dose, I.v..

5422321-6 | Anaphylactoid Reaction
on Nov 28, 2006 Male patient from UNITED STATES , 84 years of age, was treated with Myoview (View Usage). After Myoview was administered, patient had the following side effects: anaphylactoid reaction. Myoview dosage: 259 Meq, Single Dose, I.v..

5272118-5 | Diarrhoea, Fatigue, Hepatitis C, Pyrexia, Ventricular Tachycardia, Viral Infection
Patient was taking Myoview (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, fatigue, hepatitis c (What is hepatitis c?), pyrexia, ventricular tachycardia, viral infection (What is viral infection?) on Mar 20, 2007 from UNITED STATES Additional patient health information: Male patient , 66 years of age, was diagnosed with scan myocardial perfusion, cardiac stress test and. Myoview dosage: 38.9 Mci Once Iv Bolus. During the same period patient was treated with ADENOSINE (65 Mg Once Iv Bolus 1 Dose) (View Adenosine Review and Adenosine Label ), HEPARIN (View Heparin Review and Heparin Label ), CEFAZOLIN (View Cefazolin Review and Cefazolin Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), THALLIUM (View Thallium Review and Thallium Label ).

5187710-6 | Delirium, Escherichia Infection, Pneumonia, Pyrexia
Adverse event was reported on Dec 06, 2006 by a Male patient taking Myoview (View Usage) (Dosage: 370 Mbq, Single Dose, I.v.) was diagnosed with arrhythmia (What is arrhythmia?), hypertension and. Location: UNITED STATES , 44 years of age, Patient had the following side effects: delirium, escherichia infection, pneumonia (What is pneumonia?), pyrexia. Patient was hospitalized.

5165994-8 | Delirium, Escherichia Infection, Pneumonia, Pyrexia
on Nov 17, 2006 Male patient from UNITED STATES , 44 years of age, was diagnosed with arrhythmia (What is arrhythmia?), hypertension and was treated with Myoview (View Usage). After Myoview was administered, patient had the following side effects: delirium, escherichia infection, pneumonia (What is pneumonia?), pyrexia. Myoview dosage: See Image. Patient was hospitalized.

5155363-9 | Diarrhoea, Faeces Discoloured, Gastrointestinal Haemorrhage, Haematemesis, Haemoptysis, Hepatic Trauma, Intestinal Perforation, Pneumonia, Tuberculosis
on Nov 03, 2006 Male patient from UNITED STATES , 50 years of age, weighting 209.0 lb, was diagnosed with haemoptysis and was treated with Myoview (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, faeces discoloured, gastrointestinal haemorrhage, haematemesis, haemoptysis, hepatic trauma, intestinal perforation, pneumonia (What is pneumonia?), tuberculosis (What is tuberculosis?). Myoview dosage: . During the same period patient was treated with ACETAMINOPHEN AND CODEINE PHOSPHATE (View Acetaminophen And Codeine Phosphate Review and Acetaminophen And Codeine Phosphate Label ), ALBUTEROL SPIROS (View Albuterol Spiros Review and Albuterol Spiros Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), DM 10/GUIFENESEN (View Dm 10/guifenesen Review and Dm 10/guifenesen Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ). Patient was hospitalized.

5139314-9 | Diarrhoea, Fall, Haemoptysis, Hepatic Trauma, Intestinal Haemorrhage, Laceration, Malaise, Pneumonia
Patient was taking Myoview (View Usage). Patient had the following side effects: diarrhoea, fall (What is fall?), haemoptysis, hepatic trauma, intestinal haemorrhage, laceration, malaise, pneumonia (What is pneumonia?) on Oct 11, 2006 from UNITED STATES Additional patient health information: Male patient , 50 years of age, was diagnosed with haemoptysis and. Myoview dosage: , Single Dose, I.v.. During the same period patient was treated with ANTIBIOTIC (View Antibiotic Review and Antibiotic Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), ENOXAPARIN SODIUM (LOVENOX) (View Enoxaparin Sodium (lovenox) Review and Enoxaparin Sodium (lovenox) Label ), ACETAMINOPHEN/OXYCODONE (PERCOCET) (View Acetaminophen/oxycodone (percocet) Review and Acetaminophen/oxycodone (percocet) Label ).

5041452-6 | Diarrhoea, Faeces Discoloured, Gastrointestinal Haemorrhage, Haematemesis, Haemoptysis, Hepatic Trauma, Ill-defined Disorder, Intestinal Perforation
Adverse event was reported on Jun 19, 2006 by a Male patient taking Myoview (View Usage) (Dosage: Single Dose, I.v.) was diagnosed with haemoptysis and. Location: UNITED STATES , 50 years of age, After Myoview was administered, patient had the following side effects: diarrhoea, faeces discoloured, gastrointestinal haemorrhage, haematemesis, haemoptysis, hepatic trauma, ill-defined disorder, intestinal perforation.

5029729-1 | Diarrhoea, Faeces Discoloured, Haemoptysis, Hypersensitivity, Intestinal Haemorrhage, Pneumonia, Vomiting
on Jun 07, 2006 Male patient from UNITED STATES , 50 years of age, was diagnosed with haemoptysis and was treated with Myoview (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, faeces discoloured, haemoptysis, hypersensitivity, intestinal haemorrhage, pneumonia (What is pneumonia?), vomiting. Myoview dosage: Single Dose, I.v..

5020481-2 | Anaphylactoid Reaction
on May 25, 2006 Male patient from UNITED STATES , 65 years of age, weighting 173.0 lb, was diagnosed with chest pain (What is chest pain?) and was treated with Myoview (View Usage). Patient had the following side effects: anaphylactoid reaction. Myoview dosage: Single Dose, I.v..

5018824-9 | Anaphylactoid Reaction, Pruritus, Rash Erythematous, Respiratory Distress
Patient was taking Myoview (View Usage). After Myoview was administered, patient had the following side effects: anaphylactoid reaction, pruritus, rash erythematous, respiratory distress on May 25, 2006 from UNITED STATES Additional patient health information: Male patient , 65 years of age, weighting 173.0 lb, was diagnosed with chest pain (What is chest pain?) and. Myoview dosage: See Image.

4762425-4 | Dysarthria, Tongue Oedema
Adverse event was reported on Jan 06, 2005 by a Male patient taking Myoview (View Usage) (Dosage: 373.7 Mbq (single Dose) I.v.; 1121.1 Mgq (single Dose) I.v.) . Location: UNITED STATES , 67 years of age, Patient experienced the following unwanted or unexpected effects: dysarthria, tongue oedema. During the same period patient was treated with ADENOSINE (View Adenosine Review and Adenosine Label ).

4762416-3 | Hypersensitivity, Pyrexia
on Aug 20, 2004 Male patient from JAPAN , 45 years of age, was treated with Myoview (View Usage). Patient had the following side effects: hypersensitivity, pyrexia. Myoview dosage: 740 Mbq (single Dose) I.v.. During the same period patient was treated with MIDAZOLAM (View Midazolam Review and Midazolam Label ), DOPAMINE HCL (View Dopamine Hcl Review and Dopamine Hcl Label ), METHYLPREDNISOLONE SODIUM SUCCINATE (View Methylprednisolone Sodium Succinate Review and Methylprednisolone Sodium Succinate Label ), CEFTRIAXZONE (View Ceftriaxzone Review and Ceftriaxzone Label ), MINOCYCLINE HYDROCHLORIDE (View Minocycline Hydrochloride Review and Minocycline Hydrochloride Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ). Patient was hospitalized.

4698616-0 | Asthenia, Convulsion, Fatigue, Hyperhidrosis, Nausea, Syncope
on Jun 10, 2005 Male patient from , 42 years of age, was diagnosed with coronary artery disease (What is coronary artery disease?) and was treated with Myoview (View Usage). After Myoview was administered, patient had the following side effects: asthenia, convulsion, fatigue, hyperhidrosis, nausea (What is nausea?), syncope. Myoview dosage: 407 Mbq, Single, Dose, I.v.. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), PANTOPRAZOLE (PROTONIX) (View Pantoprazole (protonix) Review and Pantoprazole (protonix) Label ), PLAVIX (View Plavix Review and Plavix Label ), LIPITOR (View Lipitor Review and Lipitor Label ), ALTACE (View Altace Review and Altace Label ), ONDANSETRON HCL (View Ondansetron Hcl Review and Ondansetron Hcl Label ).

4691425-8 | Electrocardiogram St Segment Depression, Nausea
Patient was taking Myoview (View Usage). Patient experienced the following unwanted or unexpected effects: electrocardiogram st segment depression, nausea (What is nausea?) on Jun 06, 2005 from Additional patient health information: Female patient , 73 years of age, . Myoview dosage: 214.6 Mbq, Single Dose, I.v.. During the same period patient was treated with TECHNETIUM (TC99M) (GENRATOR (View Technetium (tc99m) (genrator Review and Technetium (tc99m) (genrator Label ). Patient was hospitalized.

4556538-X | Dysarthria, Swollen Tongue, Tongue Disorder
Adverse event was reported on Jan 11, 2005 by a Female patient taking Myoview (View Usage) (Dosage: 1110 Mbq, Single Dose) . Location: , 58 years of age, Patient had the following side effects: dysarthria, swollen tongue, tongue disorder. During the same period patient was treated with THALLOUS CHLORIDE TL 201 (129.5 Mbq, Single Dose) (View Thallous Chloride Tl 201 Review and Thallous Chloride Tl 201 Label ). Patient was hospitalized.

4552121-0 | Blood Pressure Decreased, Cardio-respiratory Arrest, Dyspnoea, Heart Rate Decreased
on Jan 06, 2005 Male patient from , 67 years of age, was treated with Myoview (View Usage). After Myoview was administered, patient had the following side effects: blood pressure decreased, cardio-respiratory arrest, dyspnoea, heart rate decreased. Myoview dosage: See Image. During the same period patient was treated with ADENOSINE (View Adenosine Review and Adenosine Label ).

4547101-5 | Blood Pressure Decreased, Dyspnoea, Heart Rate Decreased
on Dec 29, 2004 Male patient from , 67 years of age, was treated with Myoview (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, dyspnoea, heart rate decreased. Myoview dosage: 373.7 Mgq, Single Dose, I.v.; 1121.1 Mbq, Single Dose, I.v.. During the same period patient was treated with ADENOSINE (View Adenosine Review and Adenosine Label ).